Camerino, Italy

Pier Luigi Sparapani


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pier Luigi Sparapani: Innovator in Cancer Treatment

Introduction

Pier Luigi Sparapani is a notable inventor based in Camerino, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work focuses on the use of substance P antagonists in the treatment of adenocarcinomas, showcasing his commitment to advancing medical science.

Latest Patents

Sparapani holds a patent for the "Use of substance P antagonists in the treatment of adenocarcinomas." This patent describes the application of antagonists of neurokinin receptors (NK-1; substance P receptors) to develop a new drug effective in treating adenocarcinomas. The patent outlines that these antagonists possess specific features, including a pA >6.0 in both human and murine tissues, heterocyclic non-peptidergic structures, and experimentally demonstrated antiangiogenic effects on genito-urinary tract tumors. Furthermore, the patent indicates a decrease in tumoral mass in tumors induced by orthotopic drafts of tumoral cells in immunodeficient rats or mice.

Career Highlights

Sparapani's career is marked by his dedication to research and innovation in the medical field. His work at Biopolis S.p.a. has allowed him to collaborate with other experts and contribute to groundbreaking advancements in cancer treatment. His research has the potential to significantly impact the lives of patients suffering from adenocarcinomas.

Collaborations

Throughout his career, Sparapani has worked alongside notable colleagues, including Pierluigi Pompei and Maurizio Massi. These collaborations have fostered a productive environment for innovation and research, further enhancing the quality of their work.

Conclusion

Pier Luigi Sparapani is a distinguished inventor whose work in the treatment of adenocarcinomas exemplifies the power of innovation in medicine. His patent on substance P antagonists represents a significant step forward in cancer treatment, showcasing his expertise and dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…